Table 1.
Characteristics | n | PRDM4 expression | p value | |
---|---|---|---|---|
Positive | Negative | |||
Age, years | ||||
≤45 | 26 | 10 | 16 | 0.3052 |
>45 | 34 | 18 | 16 | |
Clinical stage | ||||
I–II | 42 | 27 | 25 | 0.0005* |
III–IV | 18 | 1 | 17 | |
SCC differentiation | ||||
Well | 15 | 8 | 7 | 0.5672 |
Moderate–poor | 45 | 20 | 25 | |
Lymph node metastasis | ||||
Absence | 48 | 26 | 22 | 0.0253* |
Present | 12 | 2 | 10 |
For comparison among groups, the χ2 test was performed. A p value <0.05 was considered statistically significant.
*p < 0.05.